Results 121 to 130 of about 1,483,986 (159)

Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

Annals of Oncology, 2017
David Fisher, M Seymour, F Elliott
exaly  

MUTANT AND CULTURE METHOD FOR MUTANT

2012
TAKEGAWA KAORU, HARA FUTOSHI, TOHDA HIDEKI, KUMAGAI HIROMICHI   +3 more
openaire   +1 more source

Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach

Ca-A Cancer Journal for Clinicians
Jyoti Malhotra, Lauren Antrim
exaly  

A phcA− marker-free mutant of Ralstonia solanacearum as potential biocontrol agent of tomato bacterial wilt

Biological Control, 2015
Guanhua Xun
exaly  

MUTANT LUCIFERASE

2007
KAWASAKI KOSEI, MORITA YOUSUKE, OHGIYA SATORU, OHMIYA YOSHIHIRO, OHYAMA YASUSHI   +4 more
openaire   +2 more sources

Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification

Ca-A Cancer Journal for Clinicians
Gilberto de Lima Lopes
exaly  

Mutant bank

2003
DENNING DAVID WEMYS, BROOKMAN JAYNE LOUISE, RICKERS ANDRE, BIRCH MIKE   +3 more
openaire   +2 more sources

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio De Vito   +2 more
exaly  

Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis

EMBO Journal, 2001
Alex Sigal, Michael Milyavsky, Naomi Goldfinger   +2 more
exaly  

STREPTAVIDIN MUTANTS

1997
SANO TAKESHI, CANTOR CHARLES R, VAJDA SANDOR, REZNIK GABRIEL O, SMITH CASSANDRA L, PANDORI MARK W   +5 more
openaire   +2 more sources